BRPI0414069A - método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinámica antimicrobiana - Google Patents

método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinámica antimicrobiana

Info

Publication number
BRPI0414069A
BRPI0414069A BRPI0414069-9A BRPI0414069A BRPI0414069A BR PI0414069 A BRPI0414069 A BR PI0414069A BR PI0414069 A BRPI0414069 A BR PI0414069A BR PI0414069 A BRPI0414069 A BR PI0414069A
Authority
BR
Brazil
Prior art keywords
treatment area
bacteria
therapeutic composition
patient
safranin
Prior art date
Application number
BRPI0414069-9A
Other languages
English (en)
Inventor
Volker Albrecht
Burkhard Gitter
Original Assignee
Ceramoptec Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceramoptec Ind Inc filed Critical Ceramoptec Ind Inc
Publication of BRPI0414069A publication Critical patent/BRPI0414069A/pt
Publication of BRPI0414069A8 publication Critical patent/BRPI0414069A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO DE DESTRUIçãO DE BACTéRIAS EM áREA DE TRATAMENTO DO PACIENTE E RESPECTIVA COMPOSIçãO TERAPêUTICA FOTODINáMICA ANTIMICROBIANA". é revelado um método e composição para destruição de micróbios, especialmente bactérias, no corpo, utilizando Safranina O em conjunção com radiação eletromagnética. Num método preferido, uma composição compreendendo Safranina O é introduzida numa área de tratamento. Após ter passado um período de tempo suficiente, é aplicada radiação de um comprimento de onda adequado na área para ativar a Safranina O e, por uma reação fotodinâmica, destruir as bactérias. A radiação preferida tem um comprimento de onda em torno de 530 nm. Este método é efetivo para a destruição tanto de bactérias Gram-positivas como de Gram-negativas e é particularmente efetivo em áreas onde estão presentes meios complexos, tais como soro sangüíneo, sangue ou saliva.
BRPI0414069A 2003-09-02 2004-08-30 Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana BRPI0414069A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49984703P 2003-09-02 2003-09-02
US10/860,296 US20050049228A1 (en) 2003-09-02 2004-06-03 Antimicrobial photodynamic therapy compound and method of use
PCT/US2004/028180 WO2005021094A2 (en) 2003-09-02 2004-08-30 Antimicrobial photodynamic therapy compound

Publications (2)

Publication Number Publication Date
BRPI0414069A true BRPI0414069A (pt) 2006-10-24
BRPI0414069A8 BRPI0414069A8 (pt) 2016-10-11

Family

ID=34221799

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414069A BRPI0414069A8 (pt) 2003-09-02 2004-08-30 Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana

Country Status (6)

Country Link
US (1) US20050049228A1 (pt)
EP (1) EP1701726B1 (pt)
JP (1) JP4828423B2 (pt)
BR (1) BRPI0414069A8 (pt)
RU (1) RU2376991C2 (pt)
WO (1) WO2005021094A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
CN103767886B (zh) 2005-11-09 2018-04-24 科洛斯科技公司 使牙齿增白的组合物及方法
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
US8906334B2 (en) 2007-05-14 2014-12-09 Invista North America S.A R.L. High efficiency reactor and process
KR20180023070A (ko) 2008-11-07 2018-03-06 클록스 테크놀로지스 인크. 히알루론산, 글루코사민 또는 알란토인을 포함하는 산화성의 광활성화된 피부 회춘용 조성물
US20120101427A1 (en) * 2009-04-28 2012-04-26 Gerard Farmer Novel photosensitizer formulations for oral administration
WO2010141564A2 (en) * 2009-06-02 2010-12-09 Ceramoptec Industries, Inc. A novel method for microbial depletion in human blood and blood products using antimicrobial photodynamic therapy
SG177635A1 (en) 2009-07-17 2012-03-29 Klox Technologies Inc Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
JP5945228B2 (ja) * 2010-01-19 2016-07-05 バイオリテック ファーマ マーケティング リミテッド 増強された抗菌ｐｄｔ
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
BR112015005593B1 (pt) 2012-09-14 2019-09-24 Valeant Pharmaceuticals International, Inc. Método para branqueamento de dentes
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
JP2017509433A (ja) 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． 組織充填剤組成物および使用方法
US10232066B2 (en) 2016-10-31 2019-03-19 Hubbell Incorporated High intensity narrow spectrum light indicator systems
US11272594B2 (en) 2016-10-31 2022-03-08 Hubbell Incorporated Multi-array lighting system for providing high intensity narrow spectrum light
EP3703763A4 (en) 2017-10-30 2021-12-08 Hubbell Incorporated ANTIMICROBIAL BACKLIT DEVICE
US11590248B2 (en) 2017-10-30 2023-02-28 Hubbell Lighting, Inc. Pulsing high intensity narrow spectrum light
RU2700407C1 (ru) * 2018-07-23 2019-09-16 Михаил Тимофеевич Александров Способ лечения опухолевых и воспалительных заболеваний с применением фотодинамической терапии
US11388789B2 (en) 2019-03-18 2022-07-12 Hubbell Lighting, Inc. Method for controlling operation of a lighting system having high intensity narrow spectrum light sources
EP4221827A4 (en) * 2020-09-30 2024-04-17 Jernigan, David, A. Method of manipulating phages within the body to attack infectious target cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798112A (en) * 1994-12-09 1998-08-25 The United States Of America As Represented By The Secretary Of Agriculture Phototoxic insecticidal composition and method for controlling insect populations
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
US5990199A (en) * 1995-04-19 1999-11-23 North American Science Associates, Inc. Indicator ink compositions
US6084005A (en) * 1997-02-24 2000-07-04 Kuraray Co., Ltd. Antimicrobial caries-detecting composition
US8187278B2 (en) * 1998-08-25 2012-05-29 Advanced Photodynamic Technologies, Inc. Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and benzalkonium chloride
US6506791B2 (en) * 2000-08-09 2003-01-14 Jacksonville State University Method of treatment of protozoan infections in fish
US6887862B2 (en) * 2001-05-31 2005-05-03 Miravant Systems, Inc. Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
JP2005502618A (ja) * 2001-06-04 2005-01-27 ザ・ジェネラル・ホスピタル・コーポレイション 光力学的化合物を用いて脆弱なプラークを検出および治療する方法
US6558653B2 (en) * 2001-09-19 2003-05-06 Scot N. Andersen Methods for treating periodontal disease
WO2005034855A2 (en) * 2003-09-05 2005-04-21 The General Hospital Corporation Photodynamic inactivation of bacterial spores

Also Published As

Publication number Publication date
US20050049228A1 (en) 2005-03-03
RU2006110554A (ru) 2006-08-10
BRPI0414069A8 (pt) 2016-10-11
EP1701726A4 (en) 2007-01-03
JP2007503917A (ja) 2007-03-01
JP4828423B2 (ja) 2011-11-30
RU2376991C2 (ru) 2009-12-27
WO2005021094A3 (en) 2005-04-28
WO2005021094A2 (en) 2005-03-10
EP1701726B1 (en) 2019-01-23
EP1701726A2 (en) 2006-09-20

Similar Documents

Publication Publication Date Title
BRPI0414069A8 (pt) Método de destruição de bactérias em área de tratamento do paciente e respectiva composição terapêutica fotodinâmica antimicrobiana
BRPI0414331A (pt) método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica
Usumez et al. Effects of laser irradiation at different wavelengths (660, 810, 980, and 1,064 nm) on mucositis in an animal model of wound healing
Caccianiga et al. Clinical, radiographic and microbiological evaluation of high level laser therapy, a new photodynamic therapy protocol, in peri‐implantitis treatment; a pilot experience
TR199802251T2 (xx) Herpes Simpleks vir�s� ve di�er enfeksiyonlu hastal�klar i�in antimikrobik tedavi i�in bile�imler.
CN1646191A (zh) 皮肤和指甲感染的防止和处理方法
Bahrami et al. Anti-biofilm and bystander effects of antimicrobial photo-sonodynamic therapy against polymicrobial periopathogenic biofilms formed on coated orthodontic mini-screws with zinc oxide nanoparticles
AU7437494A (en) A novel physiologically active substance
AU5029599A (en) Methods for eradication of nanobacteria
Theodoro et al. Effect of antimicrobial photodynamic therapy on periodontally infected tooth sockets in rats
Roncati et al. Evaluation of light-emitting diode (led-835 nm) application over human gingival fibroblast: An in vitro study
Misischia et al. Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro
CN118973622A (zh) 紫外线照射装置及紫外线照射方法
Huang et al. Enhancing osteoblast functions on biofilm-contaminated titanium alloy by concentration-dependent use of methylene blue-mediated antimicrobial photodynamic therapy
Li et al. Extracorporeal shock wave therapy: A potential adjuvant treatment for peri-implantitis
DE60330914D1 (de) Arzneimittel mit shikonin als wirkstoff
Shukla et al. Association and contribution of dentistry in creating and sharing the burden of antibiotic-resistant microbial world
BRPI0412408A (pt) métodos para a produção de um efeito de redução antiangiogênico e/ou de permeabilidade vascular e para o tratamento de um cáncer em um animal de sangue quente tal como um ser humano, composição farmacêutica, kit, e uso de azd2171 ou um sal farmaceuticamente aceitável deste e zd1839 ou um sal farmaceuticamente aceitável deste
Wainwright Maggot therapy—a backwater in the fight against bacterial infection
Sommer Antiinfectives and low-level light: a new chapter in photomedicine
RU2430757C1 (ru) Способ подавления патогенных и условно-патогенных микроорганизмов
WO2005110001A1 (en) Thermostatic and sterilization apparatus
Shukla et al. of Dentistry in Creating and Sharing
Zharov et al. Photoultrasonic treatment of septic wounds
HUSANU et al. Silver Salts in Dermatological Pathology

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: BIOLITEC PHARMA MARKETING LTD. (MY)

B25A Requested transfer of rights approved

Owner name: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG (AT)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time